CANDIDÍASE (1) 
AHLGREN, K. M. et al. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model. European journal of immunology, Weinheim, v. 41, n. 1, p. 235-245, Jan. 2011.
(2) (3) (4) (5) (6) (7) (8) (9) (10)
KUR, K. et al. Disruption of homocitrate synthase genes in Candida albicans affects growth but not virulence. Mycopathologia, The Hague, v. 170, n. 6, p. 397-402, Dec. 2010.
VAN DER VEERDONK, F. L. et al.Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy. FEMS microbiology reviews, Amsterdam, v. 34, n. 6, p. 1063-1075, Nov. 2010.
SIDRIM, J. J. C. et al. Candida species isolated from the gastrointestinal tract of cockatiels (Nymphicus hollandicus): In vitro antifungal susceptibility profile and phospholipase activity. Veterinary microbiology, Amsterdam, v. 145, n. 3/4, p. 324-328, Oct. 2010.
BORIOLLO, M. F. G. et al. Disparity between Multilocus Enzyme Electrophoresis, Microsatellite Markers and Pulsed-Field Gel Electrophoresis in epidemiological tracking of Candida albicans. Journal of microbiological methods, Amsterdam, v. 82, n. 3, p. 265-281, Sept. 2010.
CAMARGO, T. Z. S. et al. Secular trends of candidemia in a tertiary care hospital. American journal of infection control, St. Louis, v. 38, n. 7, p. 546-551, Sept. 2010.
MACÊDO, D. P. C. et al. Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported case. Medical mycology, Oxford, v. 48, n. 6, p. 862-865, Sept. 2010.
PEREIRA, G. H. et al. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. Medical mycology, Oxford, v. 48, n. 6, p. 839-842, Sept. 2010.
GARNACHO-MONTERO, J. et al. Risk factors for fluconazole-resistant candidemia. Antimicrobial agents and chemotherapy, Washington, v. 54, n. 8, p. 3149-3154, Aug. 2010.
NUCCI, M. et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clinical infectious diseases, Chicago, v. 51, n. 3, p. 295-303, Aug. 2010.
MALARIA (1) MCGREADY, R; WHITE, N.J. ; NOSTEN, F. Parasitological efficacy of antimalarials in the treatment and prevention of falciparum malaria in pregnancy 1998 to 2009: a systematic review. BJOG: An international journal of obstetrics & gynaecology, Malden, v. 118, v. 2, p.123-35, Jan. 2011. (2) THONGSAHUAN, Sorawat et al. Susceptibility of anopheles campestris-like and anopheles barbirostris species complexes to plasmodium falciparum and plasmodium vivax in Thailand. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v.106, n.1, p.105-112. Feb. 2011. (3) (4) NEWMAN, R. D. Learning to outwit malaria. Bulletin World Health Organization, Geneve, v. 89, n. 1, p.10-11, Jan. 2011. (5) BAIDEN, F. Would rational use of antibiotics be compromised in the era of test-based management of malaria? Tropical Medicine & International Health, Oxford, v. 16, n. 2, p. 142-144,, Feb., 2011. 
FERREIRA, M. E. S. et al. Metemoglobinemia em pacientes com malária por Plasmodium vivax em uso oral de primaquina. Revista da Sociedade Brasileira de Medicina Tropical, Uberaba, v. 44, n.1, p. 113-115, jan./feb., 2011.
(1) (2) TORRES POMBERT, A. Diseño de sistemas internos de propiedad intelectual en el modelo cubano: una propuesta metodológica. ACIMED , Vedado, 2010, v.21, n.1, p. 44-56, 2010. (3) SORIA, A. F. Geração de patentes em universidades: um estudo exploratório. Revista de administração FACES journal, Belo Horizonte , v. 9 • n. 3, p. 95 -116 , jul./set. 2010. (4) FEDERMAN, S. Regina. Publicar ou depositar a patente? Conhecimento & Inovação, Campinas, SP, v. 6, n. 1, p. 48-49. 2010. (5) CHAMAS, C. I. Comércio internacional, patentes e saúde pública . RECIIS – Revista eletrônica de comunicação, informação e inovação em saúde, Rio de Janeiro, v. 4, n. 1, p. 177-180, mar., 2010.
LEVENSON, D. Department of justice opposes patents on isolated genes. American journal of medical genetics, New Jersey, v. 155, n. 2, p. vii-viii., Feb. 2011.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
